ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

APZ Aptilon Corporation

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Aptilon Corporation TSXV:APZ TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Aptilon Announces Update on Delay in Filing Year-End Financial Statements

01/06/2012 10:00pm

PR Newswire (Canada)


Aptilon Corporation (TSXV:APZ)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Aptilon Corporation Charts.
MONTREAL, June 1, 2012 /CNW/ - Aptilon Corporation ("Aptilon or the "Company") , a leader in online access, engagement and interaction with physicians and healthcare professionals on behalf of pharmaceutical and life sciences companies, today announced that it continues to work towards finalizing the Company's audited annual financial statements for the year ended December 31, 2011, including the related management discussion and analysis, and CEO and CFO certifications (collectively, the "Annual Financial Filings"). On May 25, 2012, the notice of change of auditor was filed, as announced. The new auditors were provided access to the files from the former auditors to perform required transition work. Aptilon is working towards the target date of June 15, 2012 to file its Annual Financial Filings. On May 30, 2012, the Company announced that the Interim Filings for the period ended March 31, 2012 would not be made by the required filing deadline of May 30, 2012. The Company expects that the Interim Filings will be made simultaneously with the annual filings or shortly thereafter. About Aptilon Corporation Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through: video and mobile detailing, ReachNet(SM) Physician Access Channel, the DMD database and permission-based email services. Top US pharmaceutical companies and respected healthcare organizations have adopted Aptilon's solutions to market to, engage and interact with leading healthcare practitioners. For more information, visit www.aptilon.com. ReachNet(SM) is a service mark of Aptilon Corporation, other trademarks are the property of their respective owners. Forward-looking statements This news release may contain forward-looking statements. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Aptilon Corporation CONTACT: Mr. Denis MartineauPresidentAptilon Corporation1-888-544-8866investors@aptilon.com

Copyright

1 Year Aptilon Corporation Chart

1 Year Aptilon Corporation Chart

1 Month Aptilon Corporation Chart

1 Month Aptilon Corporation Chart